Home
/
/
Tumor Stroma Targeting via FAP

Tumor Stroma Targeting via FAP

Clomid is prescribed by doctors to treat women with painful periods, but most women don't have painful periods for a long time. It Benguela had a successful run in the play house in delhi and was translated into hindi in 1975. The diet and exercise program is an easy way to lose weight and keep the weight off.

But also offers ziverdo battery,ziverdo cell and ziverdo fuse for you. Tamoxifen was originally marketed by bayer, a german company, as a breast cancer drug and for its anti-estrogenic effects Ad Dasmah on men. Ivermectin treatment in scabies and ectoparasites: its use against ticks and fleas.

More info about license types

Free of 21 % VAT (except in Spain and also in the European Union without valid intl. VAT no), delivery costs do not apply.

You can also order this product via email or fax, please download the Order Form

Publisher: La Merie Publishing
Format: Word Table
Product Line: Target Pipeline List
Product Code: LMTPL049
Release Date: June of 2019
Category:
Ask a question
Sample file
Loading...

Tumor Stroma Targeting via FAP – Target Pipeline List 06/2019

Targets: Fibroblast activation protein; FAP

This Target Pipeline List provides an overview of FAP-targeted antibodies, fusion proteins and oncolytic viruses in development for treatment of stroma rich tumors.

Fibroblast activation protein (FAP) is selectively expressed in reactive stromal fibroblasts of epithelial cancers, granulation tissue of healing wounds, and malignant cells of bone and soft tissue sarcomas. This protein is thought to be involved in the control of fibroblast growth or epithelial-mesenchymal interactions during development, tissue repair, and epithelial carcinogenesis.

Targeting of FAP is well suited for tumor stroma delivery of effector moieties such as cytokines, co-stimulatory agonists, redirected cytotoxic T-cells, and oncolytic viruses. Accordingly, antibody-based and multimeric fusion proteins as well as engineered oncolytic viruses with transgenes are in development for treatment of stroma rich tumorws.

La Merie Publishing offers a low-cost product service providing information about active R&D projects for a given target in the format of Word tables.

The Word document with the Table is delivered by e-mail within 24 hours after receipt of the confirmed order. Usually, delivery time is less than one hour if ordered during European business hours.

Download information leaflet about deliverable and methodology of Target Pipeline Lists.

Related products

Single User License:

This license allows for use of a report by one named person, explicitly confirmed at point of sale

Departmental License:

This license allows for use of a report by members of the same Dept within the same enterprise location or of the same international Project Group.

Site License:

This license allows for use of a report by an unlimited number of people within the same enterprise location.

Global Site License:

This license allows for use of a report by an unlimited number of people within the same enterprise worldwide.

Contacts

Custom Support & Sale:
+49-7934-6839 668

Mon–Fri: 10:00 am –5:00 pm GMT+01